🍼 PubMed Studies on Lactobacillus gasseri KS-13 Lactobacillus gasseri KS-13

Citations are updated once a week. Recently added citations may not appear.

2 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
Lactobacillus gasseri KS-13    ? Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial.
The American journal of clinical nutrition (Am J Clin Nutr ) Vol: 105 Issue 3 Pages: 758-767
Pub: 2017 Mar Epub: 2017 Feb 22 Authors Dennis-Wall JC , Culpepper T , Nieves C Jr , Rowe CC , Burns AM , Rusch CT , Federico A , Ukhanova M , Waugh S , Mai V , Christman MC , Langkamp-Henken B ,
Publication
Lactobacillus gasseri KS-13    ? Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Journal of the American College of Nutrition (J Am Coll Nutr ) Vol: 34 Issue 6 Pages: 459-69
Pub: 2015 Epub: 2015 Apr 24 Authors Spaiser SJ , Culpepper T , Nieves C Jr , Ukhanova M , Mai V , Percival SS , Christman MC , Langkamp-Henken B ,
Publication

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.